Dallas, Texas 04/03/2014 (FINANCIALSTRENDS) – Increases Allergan Inc. (NYSE:AGN) Price with Target to $140.00, by Citigroup Inc.
Research examiners at Citigroup Inc. lifted their value focus on shares of Allergan Inc. (NYSE:AGN) from $130.00 to $140.00 in a report discharged on Friday. The firm presently has a “purchase” rating on the stock. Citigroup Inc. Target value might show a potential upside of 12.81% from the organization’s current cost.
Experts comment on the stock
A few different experts have likewise as of late remarked on the stock. Examiners at Barclays raised their value focus on shares of Allergan Inc. (NYSE:AGN) from $95.00 to $130.00 in an examination note on March. They now have an “equivalent weight” rating on the stock. Independently, experts at BMO Capital Markets raised their value focus on shares of Allergan from $128.00 to $140.00 in an examination note on Tuesday, February 25th. At long last, examiners at Jpmorgan Chase & Co. raised their value focus on shares of Allergan Inc. (NYSE:AGN) from $115.00 to $130.00 in an exploration note on Wednesday, February twelfth. Six financing experts have appraised the stock with a hold rating and fourteen have purchase.
Allergan Inc. (NYSE:AGN) exchanged down 0.38% throughout mid-day exchanging on Friday, hitting $123.63. 1,764,027 shares of the organization’s stock exchanged hands. Allergan has a 1-year low of $81.33 and a 1-year high of $132.04. The stock’s 50-day moving normal is $126.2 and its 200-day moving normal is $106.7. The organization has a business top of $36.899 billion and a cost to-income degree of 38.07.
Profit report announced
Allergan Inc. (NYSE:AGN) last discharged its profit information on Tuesday, February fourth. The organization reported $1.12 income for every offer for the quarter, missing the experts’ agreement evaluation of $1.34 by $0.22. The organization had income of $1.66 million for the quarter, contrasted with the agreement appraisal of $1.65 million. Throughout the same quarter a year ago, the organization posted $1.15 income for every offer. Allergan’s income was up 14.4% contrasted with the same quarter a year ago. Experts want that Allergan Inc. (NYSE:AGN) will post $5.47 EPS for the current financial year.